EnWave Signs Master Service Agreement and First Work Order with BioTechnique LLC
Globenewswire·2025-03-27 13:00
VANCOUVER, British Columbia, March 27, 2025 (GLOBE NEWSWIRE) -- EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the "Company") announced today that it has signed a master service agreement (the “Agreement”) with BioTechnique, an American pharmaceutical contract manufacturing service provider. This Agreement outlines the terms for the continued evaluation by BioTechnique of EnWave’s Radiant Energy Vacuum (“REV™”) dehydration technology as a suitable replacement for lyophilization in the biopharmaceuti ...